NBIX

Neurocrine Biosciences, Inc.  (NASDAQ:NBIX) Short Interest Down 17.1% in May

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Short Interest Down 17.1% in May

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totaling 3,580,000 shares, a drop of 17.1% from the May 15th total of 4,320,000 shares. Based on an average daily volume of 734,800 shares, the short-interest ratio is …

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Short Interest Down 17.1% in May Read More »

Neurocrine Biosciences, Inc.  (NASDAQ:NBIX) Short Interest Down 17.1% in May

Neurocrine Biosciences, Inc. to Post FY2023 Earnings of $2.48 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) – Equities researchers at Cantor Fitzgerald issued their FY2023 earnings per share estimates for shares of Neurocrine Biosciences in a research note issued on Monday, June 6th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn $2.48 per share for the year. Neurocrine Biosciences (NASDAQ:NBIX – …

Neurocrine Biosciences, Inc. to Post FY2023 Earnings of $2.48 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:NBIX) Read More »